Hilsenbeck SG - Search Results

1

Correction to: Hormonal modulation of ESR1 mutant metastasis.

Gu G, Tian L, Herzog SK, Rechoum Y, Gelsomino L, Gao M, Du L, Kim JA, Dustin D, Lo HC, Beyer AR, Edwards DG, Gonzalez T, Tsimelzon A, Huang HJ, Fernandez NM, Grimm SL, Hilsenbeck SG, Liu D, Xu J, Alaniz A, Li S, Mills GB, Janku F, Kittler R, Zhang XH, Coarfa C, Foulds CE, Symmans WF, Andò S, Fuqua SAW. Gu G, et al. Among authors: hilsenbeck sg. Oncogene. 2022 Jan;41(3):460. doi: 10.1038/s41388-021-02104-w. Oncogene. 2022. PMID: 34782721 No abstract available.

2

Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.

Zhang QX, Hilsenbeck SG, Fuqua SA, Borg A. Zhang QX, et al. Among authors: hilsenbeck sg. J Steroid Biochem Mol Biol. 1996 Nov;59(3-4):251-60. doi: 10.1016/s0960-0760(96)00120-3. J Steroid Biochem Mol Biol. 1996. PMID: 9010317

3

Sp1 is essential for estrogen receptor alpha gene transcription.

deGraffenried LA, Hilsenbeck SG, Fuqua SA. deGraffenried LA, et al. Among authors: hilsenbeck sg. J Steroid Biochem Mol Biol. 2002 Sep;82(1):7-18. doi: 10.1016/s0960-0760(02)00151-6. J Steroid Biochem Mol Biol. 2002. PMID: 12429135

4

Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates.

Hopp TA, Weiss HL, Hilsenbeck SG, Cui Y, Allred DC, Horwitz KB, Fuqua SA. Hopp TA, et al. Among authors: hilsenbeck sg. Clin Cancer Res. 2004 Apr 15;10(8):2751-60. doi: 10.1158/1078-0432.ccr-03-0141. Clin Cancer Res. 2004. PMID: 15102680

5

Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.

DeNardo DG, Kim HT, Hilsenbeck S, Cuba V, Tsimelzon A, Brown PH. DeNardo DG, et al. Mol Endocrinol. 2005 Feb;19(2):362-78. doi: 10.1210/me.2004-0267. Epub 2004 Oct 28. Mol Endocrinol. 2005. PMID: 15514030

6

Genomic approaches to understanding and treating breast cancer.

Fuqua SA, Chang JC, Hilsenbeck SG. Fuqua SA, et al. Among authors: hilsenbeck sg. Breast Dis. 2004;19:35-46. doi: 10.3233/bd-2004-19106. Breast Dis. 2004. PMID: 15687696

7

Genomic approaches in the management and treatment of breast cancer.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Among authors: hilsenbeck sg. Br J Cancer. 2005 Feb 28;92(4):618-24. doi: 10.1038/sj.bjc.6602410. Br J Cancer. 2005. PMID: 15714204 Free PMC article. Review.

8

The promise of microarrays in the management and treatment of breast cancer.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Among authors: hilsenbeck sg. Breast Cancer Res. 2005;7(3):100-4. doi: 10.1186/bcr1018. Epub 2005 Apr 1. Breast Cancer Res. 2005. PMID: 15987438 Free PMC article. Review.

9

Transcriptional profiling of mammary gland side population cells.

Behbod F, Xian W, Shaw CA, Hilsenbeck SG, Tsimelzon A, Rosen JM. Behbod F, et al. Among authors: hilsenbeck sg. Stem Cells. 2006 Apr;24(4):1065-74. doi: 10.1634/stemcells.2005-0375. Epub 2005 Nov 10. Stem Cells. 2006. PMID: 16282442

10

Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.

Cui Y, Parra I, Zhang M, Hilsenbeck SG, Tsimelzon A, Furukawa T, Horii A, Zhang ZY, Nicholson RI, Fuqua SA. Cui Y, et al. Among authors: hilsenbeck sg. Cancer Res. 2006 Jun 1;66(11):5950-9. doi: 10.1158/0008-5472.CAN-05-3243. Cancer Res. 2006. PMID: 16740736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page